Clinical Trial Update: Nationwide Cohort Study of Antiplatelet Agents as Primary Prevention

View source ↗

Summary

A nationwide cohort study evaluating antiplatelet agents for primary prevention in people with coronary artery disease or coronary artery stenosis has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Artery Stenosis

Drugs mentioned

• Antiplatelet agents (multiple)

Snippet

Sponsor: Samsung Medical Center | Conditions: Coronary Artery Disease, Coronary Artery Stenosis | Status: COMPLETED